Literature DB >> 19457105

Calpain-mediated activation of NO synthase in human neuroblastoma SK-N-BE cells.

Monica Averna1, Roberto Stifanese, Roberta De Tullio, Francesco Beccaria, Franca Salamino, Sandro Pontremoli, Edon Melloni.   

Abstract

In resting human neuronal cells, nitric oxide synthase (nNOS) is present in its native 160 kDa form in a quiescent state predominantly co-localized on the plasma membrane, via its PDZ (Psd-95/Discs-large/Zona Occludens) domain, with NMDA receptor (NMDA-R) and in tight association with heat shock protein 90 (HSP90). Following exposure of the cells to Ca(2+)-ionophore or to NMDA, nNOS undergoes proteolytic removal of the PDZ domain being converted into a fully active 130 kDa form. The newly generated nNO synthase form dissociates from NMDA-R and extensively diffuses into the cytosol in direct correlation with NO production. Intracellular redistribution and activation of nNOS are completely prevented in cells preloaded with calpain inhibitor-1, indicating that these processes are triggered by a concomitant activation of calpain. The role of calpain has been confirmed by immunoprecipitation experiments revealing that also mu-calpain is specifically recruited into the NMDA-R-nNOS-HSP90 complex following calcium loading. Thus, the formation of clusters containing HSP90, mu-calpain, nNOS and NMDA-R represents the limiting step for the operation of the mechanism that links an efficient synthesis of NO to a local increase in Ca(2+) influx.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457105     DOI: 10.1111/j.1471-4159.2009.06149.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

Review 2.  Calpains as potential anti-cancer targets.

Authors:  Ludovic Leloup; Alan Wells
Journal:  Expert Opin Ther Targets       Date:  2011-01-19       Impact factor: 6.902

3.  Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis.

Authors:  Roberto Stifanese; Monica Averna; Roberta De Tullio; Marco Pedrazzi; Francesco Beccaria; Franca Salamino; Marco Milanese; Giambattista Bonanno; Sandro Pontremoli; Edon Melloni
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

4.  Physiological Roles of Calpain 1 Associated to Multiprotein NMDA Receptor Complex.

Authors:  Monica Averna; Matteo Pellegrini; Chiara Cervetto; Marco Pedrazzi; Margherita Bavestrello; Roberta De Tullio; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

5.  Interaction between calpain-1 and HSP90: new insights into the regulation of localization and activity of the protease.

Authors:  Monica Averna; Roberta De Tullio; Marco Pedrazzi; Margherita Bavestrello; Matteo Pellegrini; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  PLoS One       Date:  2015-01-09       Impact factor: 3.240

6.  Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein.

Authors:  Marco Pedrazzi; Monica Averna; Bianca Sparatore; Mauro Patrone; Franca Salamino; Manuela Marcoli; Guido Maura; Chiara Cervetto; Daniela Frattaroli; Sandro Pontremoli; Edon Melloni
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

7.  A Bioactive Olive Pomace Extract Prevents the Death of Murine Cortical Neurons Triggered by NMDAR Over-Activation.

Authors:  Alice Franchi; Marco Pedrazzi; Alessandro Alberto Casazza; Enrico Millo; Gianluca Damonte; Annalisa Salis; Nara Liessi; Franco Onofri; Antonella Marte; Silvia Casagrande; Roberta De Tullio; Patrizia Perego; Monica Averna
Journal:  Molecules       Date:  2020-09-24       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.